NCT01563120View on ClinicalTrials.gov

A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions

Gestational Diabetes Mellitus

Interventions

DRUG

metformin

metformin up to 2550mg per day.

DRUG

glybenclamide

glybenclamide up to 20mg per day.

Trial Locations (1)

Unknown

Dep. OB/GYN, Emek Medical Center, Afula

All Listed Sponsors

lead

HaEmek Medical Center, Israel

OTHER

NCT01563120 - A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter